Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Details | |
|---|---|---|---|---|
INCYTE CORPListing on record | AwardD (derivative) | — | SEC | |
INCYTE CORPListing on record | AwardD (derivative) | — | SEC | |
INCYTE CORPListing on record | Award | — | SEC | |
INCYTE CORPListing on record | Other | $558.5K | SEC | |
INCYTE CORPListing on record | Exercise | — | SEC | |
INCYTE CORPListing on record | AwardD (derivative) | — | SEC | |
INCYTE CORPListing on record | AwardD (derivative) | — | SEC | |
INCYTE CORPListing on record | Award | — | SEC | |
INCYTE CORPListing on record | AwardD (derivative) | — | SEC | |
Syndax Pharmaceuticals IncListing on record | Award | — | SEC | |
Karuna Therapeutics, Inc.Listing unverified | Other | $6.3M | SEC | |
Karuna Therapeutics, Inc.Listing unverified | OtherD (derivative) | $8.6M | SEC | |
Karuna Therapeutics, Inc.Listing unverified | OtherD (derivative) | $12.8M | SEC | |
Karuna Therapeutics, Inc.Listing unverified | Other | $3.4M | SEC | |
Karuna Therapeutics, Inc.Listing unverified | AwardD (derivative) | — | SEC | |
Syndax Pharmaceuticals IncListing on record | Award | — | SEC | |
Karuna Therapeutics, Inc.Listing unverified | Other | $2.7M | SEC | |
Syndax Pharmaceuticals IncListing on record | Sell | $716.1K | SEC | |
Syndax Pharmaceuticals IncListing on record | Sell | $491K | SEC | |
Syndax Pharmaceuticals IncListing on record | Exercise | $248.9K | SEC | |
Syndax Pharmaceuticals IncListing on record | ExerciseD (derivative) | — | SEC | |
Syndax Pharmaceuticals IncListing on record | Exercise | $227.3K | SEC | |
Syndax Pharmaceuticals IncListing on record | Sell | $490.8K | SEC | |
Syndax Pharmaceuticals IncListing on record | ExerciseD (derivative) | — | SEC | |
Syndax Pharmaceuticals IncListing on record | Exercise | $189.1K | SEC |